Access cutting-edge trauma injury treatment through this clinical trial at a research site in Little Rock. Study-provided care at no cost to qualified participants.
Access trauma injury specialists in Little Rock at no cost
This study follows strict safety protocols and ethical guidelines
All study-related trauma injury treatment provided free
The MATIC-2 is a multicenter clinical trial enrolling children who are less than 18 years of age with hemorrhagic shock potentially needing significant blood transfusion. The primary objective of the clinical trial is to determine the effectiveness of Low Titer Group O Whole Blood (LTOWB) compared to component therapy (CT), and Tranexamic Acid (TXA) compared to placebo in decreasing 24-hour all-cause mortality in children with traumatic life threatening hemorrhage.
Sponsor: Philip Spinella
Check if you qualify for this trauma injury clinical trial in Little Rock, AR
If you're searching for trauma injury treatment options in Little Rock, AR, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Little Rock research site is actively enrolling participants for this clinical trial. You'll receive care from experienced trauma injury specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.